News|Articles|September 25, 2023
Changing regulatory environment for nitrosamine impurities
Author(s)SGS Health Science
This SGS Health Science whitepaper uncovers the changing regulatory environment, and the challenges posed by the detection of nitrosamine impurities in drug products.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
2
Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization
3
BioPharm Weekly News Roundup—Week of Oct. 27, 2025
4
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
5
